MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism - Wikidata - awgldk - TriplyDB

MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism

MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism

http://www.wikidata.org/entity/Q24626837

about

MUC1: a multifaceted oncoprotein with a key role in cancer progression.Protein mislocalization: mechanisms, functions and clinical applications in cancer.The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.MUC1 and metastatic cancer: expression, function and therapeutic targeting.Targeting malignant mitochondria with therapeutic peptides.Mitochondrial targeted peptides for cancer therapy.MUC1 (CD227): a multi-tasked molecule.MUC1 in hematological malignancies.Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.

P2860

Q33880143-7E922D41-4607-4F87-8CD6-063833AFE2B5 Q34076405-89A567FC-26FC-4B62-9E55-67C67D222D2E Q36544576-5DEC9C5D-AA5E-4B3E-8BF1-D15031974D09 Q37636939-8EFE8D84-E554-407D-8AC8-07CB19FE6F61 Q38040407-1F8FF2F0-54A5-4295-BBE5-BD0E0DCDCF64 Q38542765-63CC3C5F-0DF6-405B-B761-96BC851A6596 Q38570769-9FC4506C-F760-4E85-97DF-4A6D51F9A1E7 Q38878148-48F975CA-7C13-4BEA-A60C-6BFFD2CB25D4 Q39063057-A317FF87-ED27-47D4-BF24-78FA0C8A7A1C

P2860

MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism

http://www.wikidata.org/entity/Q24626837

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@ast

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@en

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@nl

type

label

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@ast

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@en

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@nl

prefLabel

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@ast

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@en

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@nl

P1433

Q24626837-ADE416D2-BDB4-411B-A6D7-45E418761F1A

P1476

Q24626837-C0AD350D-6547-44B7-B50B-B6146A2D1791

P2093

Q24626837-596E08DF-540A-4130-A479-3E8AB6B2FB60

P2860

Q24626837-069079E5-DA88-4C7C-A329-1FBD8867E17C

Q24626837-0FED9802-46BB-4AA3-A642-07BD2F44DE0C

Q24626837-10416ADE-3598-4024-8A17-9CFF75D0079E

Q24626837-143BC22C-461A-4008-BE44-4507A1A7BC57

Q24626837-2B4565EF-0E77-4A3B-A9BA-3B30CD280E1E

Q24626837-35E8E4D2-BB99-4FF6-B5CC-9A5CE33EF53A

Q24626837-3BAA23D3-29FB-4E32-BEED-7C925E3FC10D

Q24626837-3D023E65-1908-47B1-989E-28970F7EEE82

Q24626837-3F537586-6F02-4B07-A765-F5E962BCF79E

Q24626837-48843486-4872-4BC9-AFA7-CA98D6BF4AAC

P304

Q24626837-801CBE5F-EF97-4C0C-BA27-E0FA7159BD6A

P31

Q24626837-17B80EB1-3786-4F02-BF95-BDE5F0E7045E

P356

Q24626837-F62C95AC-DBB4-48D2-8F1E-C94CE4819DBE

P407

Q24626837-F8CC966B-4803-4208-A898-DDA86E55449A

P433

Q24626837-2A1E6FA1-E8CD-42A8-90E6-93F6FC72165C

P478

Q24626837-7AF919DB-E496-48BF-84DC-6A85AAABF6D2

P50

Q24626837-EC3A1BF2-C4A3-471D-9243-B49FD59D6BEF

P577

Q24626837-DDCDCB7E-22C6-4A8B-9822-3C5A6953859B

P5875

Q24626837-6D346795-8682-43CB-81E8-9E10E3B6C85B

P698

Q24626837-F16584C0-2F5F-4F30-8B00-93949E9C01FF

P921

Q24626837-84D433CF-5A84-4A2B-80E9-F2212F5104C2

P932

Q24626837-CD7CBCC1-AFA8-4871-B41E-EC944913070D

P356

1947601911405044

P1433

P1476

MUC1-C Oncoprotein Blocks Term ...... ls by a ROS-Mediated Mechanism

@en

P2093

Li Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation

Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin

Mucins in cancer: function, prognosis and therapy

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

Functional interaction between beta-catenin and FOXO in oxidative stress signaling

Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin

Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells

P304

56-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1947601911405044

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51193786

http://www.w3.org/2001/XMLSchema#string

P698

21643558

http://www.w3.org/2001/XMLSchema#string

P921

P932

3107545

http://www.w3.org/2001/XMLSchema#string